SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Matthieu F. Bastide, Brice de la Crompe, Evelyne Doudnikoff, Pierre-Olivier Fernagut, Christian E. Gross, Nicolas Mallet, Thomas Boraud, Erwan Bézard, Inhibiting Lateral Habenula Improves L-DOPA–Induced Dyskinesia, Biological Psychiatry, 2016, 79, 5, 345

    CrossRef

  2. 2
    Veronica Ghiglieri, Desiree Mineo, Anna Vannelli, Fabrizio Cacace, Maria Mancini, Valentina Pendolino, Francesco Napolitano, Anna di Maio, Manuela Mellone, Jennifer Stanic, Elisabetta Tronci, Camino Fidalgo, Roberto Stancampiano, Manolo Carta, Paolo Calabresi, Fabrizio Gardoni, Alessandro Usiello, Barbara Picconi, Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms, Neurobiology of Disease, 2016, 86, 140

    CrossRef

  3. 3
    Manolo Carta, M. Angela Cenci, On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats, Movement Disorders, 2016, 31, 1
  4. 4
    Michel Engeln, Matthieu F. Bastide, Estelle Toulmé, Benjamin Dehay, Mathieu Bourdenx, Evelyne Doudnikoff, Qin Li, Christian E. Gross, Eric Boué-Grabot, Antonio Pisani, Erwan Bezard, Pierre-Olivier Fernagut, Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA–Induced Dyskinesia, Biological Psychiatry, 2016, 79, 5, 354

    CrossRef

  5. 5
    Andrew C. McCreary, Mark A. Varney, Adrian Newman-Tancredi, The Novel 5-HT1A Receptor Agonist, NLX-112 Reduces L-DOPA-induced Abnormal Involuntary Movements in Rat: a Chronic Administration Study with Microdialysis Measurements, Neuropharmacology, 2016,

    CrossRef

  6. 6
    H. Iderberg, A.C. McCreary, M.A. Varney, M.A. Cenci, A. Newman-Tancredi, Activity of serotonin 5-HT1A receptor ‘biased agonists’ in rat models of Parkinson's disease and l-DOPA-induced dyskinesia, Neuropharmacology, 2015, 93, 52

    CrossRef

  7. 7
    E. Bezard, M. Carta, Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?, Brain, 2015, 138, 4, 829

    CrossRef

  8. 8
    Nicolas Morin, Marc Morissette, Laurent Grégoire, Thérèse Di Paolo, Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015, 56, 27

    CrossRef

  9. 9
    E. Tronci, C. Fidalgo, R. Stancampiano, M. Carta, Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats, Behavioural Brain Research, 2015, 292, 300

    CrossRef

  10. 10
    C. Fidalgo, W.K.D. Ko, E. Tronci, Q. Li, R. Stancampiano, Q. Chuan, E. Bezard, M. Carta, Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson’s disease, Neuroscience, 2015, 298, 389

    CrossRef

  11. 11
    P. Svenningsson, C. Rosenblad, K. af Edholm Arvidsson, K. Wictorin, C. Keywood, B. Shankar, D. A. Lowe, A. Bjorklund, H. Widner, Eltoprazine counteracts L-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study, Brain, 2015, 138, 4, 963

    CrossRef

  12. 12
    Giovanna Paolone, Alberto Brugnoli, Ludovico Arcuri, Daniela Mercatelli, Michele Morari, Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity, Movement Disorders, 2015, 30, 13
  13. 13
    Xinxin Yang, Hui Zhao, Hongjuan Shi, Xiaoying Wang, Shenyang Zhang, Zunsheng Zhang, Jie Zu, Wei Zhang, Xia Shen, Guiyun Cui, Fang Hua, Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease, Experimental Neurology, 2015, 271, 168

    CrossRef

  14. 14
    Yukihiro Ohno, Saki Shimizu, Kentaro Tokudome, Naofumi Kunisawa, Masashi Sasa, New insight into the therapeutic role of the serotonergic system in Parkinson's disease, Progress in Neurobiology, 2015, 134, 104

    CrossRef

  15. 15
    H. Iderberg, A.C. McCreary, M.A. Varney, M.S. Kleven, W. Koek, L. Bardin, R. Depoortère, M.A. Cenci, A. Newman-Tancredi, NLX-112, a novel 5-HT1A receptor agonist for the treatment of l-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat, Experimental Neurology, 2015, 271, 335

    CrossRef

  16. 16
    Matthieu F. Bastide, Wassilios G. Meissner, Barbara Picconi, Stefania Fasano, Pierre-Olivier Fernagut, Michael Feyder, Veronica Francardo, Cristina Alcacer, Yunmin Ding, Riccardo Brambilla, Gilberto Fisone, A. Jon Stoessl, Mathieu Bourdenx, Michel Engeln, Sylvia Navailles, Philippe De Deurwaerdère, Wai Kin D. Ko, Nicola Simola, Micaela Morelli, Laurent Groc, Maria-Cruz Rodriguez, Eugenia V. Gurevich, Maryka Quik, Michele Morari, Manuela Mellone, Fabrizio Gardoni, Elisabetta Tronci, Dominique Guehl, François Tison, Alan R. Crossman, Un Jung Kang, Kathy Steece-Collier, Susan Fox, Manolo Carta, M. Angela Cenci, Erwan Bézard, Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease, Progress in Neurobiology, 2015, 132, 96

    CrossRef

  17. 17
    J.-Y. Lee, S. Seo, J. S. Lee, H.-J. Kim, Y. K. Kim, B. S. Jeon, Putaminal serotonergic innervation: Monitoring dyskinesia risk in Parkinson disease, Neurology, 2015, 85, 10, 853

    CrossRef

  18. 18
    Marios Politis, Flavia Niccolini, Serotonin in Parkinson's disease, Behavioural Brain Research, 2015, 277, 136

    CrossRef

  19. 19
    D Lindenbach, N Palumbo, C Y Ostock, N Vilceus, M M Conti, C Bishop, Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats, British Journal of Pharmacology, 2015, 172, 1
  20. 20
    Philippe Huot, Tom H. Johnston, Susan H. Fox, Adrian Newman-Tancredi, Jonathan M. Brotchie, The highly-selective 5-HT1A agonist F15599 reduces l-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque, Neuropharmacology, 2015, 97, 306

    CrossRef

  21. 21
    Danhui Zhang, Matthew McGregor, Tanuja Bordia, Xiomara A. Perez, J. Michael McIntosh, Michael W. Decker, Maryka Quik, α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage, Movement Disorders, 2015, 30, 14
  22. 22
    Ferdinando Fiorino, Beatrice Severino, Elisa Magli, Antonio Ciano, Giuseppe Caliendo, Vincenzo Santagada, Francesco Frecentese, Elisa Perissutti, 5-HT1AReceptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer, Journal of Medicinal Chemistry, 2014, 57, 11, 4407

    CrossRef

  23. 23
    Clare J. Finlay, Susan Duty, Anthony C. Vernon, Brain Morphometry and the Neurobiology of Levodopa-Induced Dyskinesias: Current Knowledge and Future Potential for Translational Pre-Clinical Neuroimaging Studies, Frontiers in Neurology, 2014, 5,

    CrossRef

  24. 24
    Carole Hyacinthe, Quentin Barraud, François Tison, Erwan Bezard, Imad Ghorayeb, D1 receptor agonist improves sleep–wake parameters in experimental parkinsonism, Neurobiology of Disease, 2014, 63, 20

    CrossRef

  25. 25
    E. Tronci, C. Fidalgo, E. Zianni, M. Collu, R. Stancampiano, M. Morelli, F. Gardoni, M. Carta, Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease, Neuroscience, 2014, 265, 245

    CrossRef

  26. 26
    Wai Kin D. Ko, Qin Li, Erwan Bezard, Effects of l-tryptophan on l-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease, Neuroscience Letters, 2014, 566, 72

    CrossRef

  27. 27
    Dmitry Petrov, Ignacio Pedros, Maria Luisa de Lemos, Mercè Pallàs, Anna Maria Canudas, Alberto Lazarowski, Carlos Beas-Zarate, Carme Auladell, Jaume Folch, Antoni Camins, Mavoglurant as a treatment for Parkinson’s disease, Expert Opinion on Investigational Drugs, 2014, 23, 8, 1165

    CrossRef

  28. 28
    Eva Schaeffer, Andrea Pilotto, Daniela Berg, Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease, CNS Drugs, 2014, 28, 12, 1155

    CrossRef

  29. 29
    Ana P. Abdala, John M. Bissonnette, Adrian Newman-Tancredi, Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists, Frontiers in Physiology, 2014, 5,

    CrossRef

  30. 30
    M. Angela Cenci, Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications, Frontiers in Neurology, 2014, 5,

    CrossRef

  31. 31
    Maryka Quik, Danhui Zhang, Xiomara A. Perez, Tanuja Bordia, Role for the nicotinic cholinergic system in movement disorders; therapeutic implications, Pharmacology & Therapeutics, 2014, 144, 1, 50

    CrossRef

  32. 32
    Marios Politis, Kit Wu, Clare Loane, David J. Brooks, Lorenzo Kiferle, Federico E. Turkheimer, Peter Bain, Sophie Molloy, Paola Piccini, Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients, Journal of Clinical Investigation, 2014, 124, 3, 1340

    CrossRef

  33. 33
    N. Nevalainen, S. af Bjerkén, G.A. Gerhardt, I. Strömberg, Serotonergic nerve fibers in l-DOPA-derived dopamine release and dyskinesia, Neuroscience, 2014, 260, 73

    CrossRef

  34. 34
    Manolo Carta, Elisabetta Tronci, Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations, Frontiers in Neurology, 2014, 5,

    CrossRef

  35. 35
    Albert Y. Hung, Michael A. Schwarzschild, Treatment of Parkinson’s Disease: What’s in the Non-dopaminergic Pipeline?, Neurotherapeutics, 2014, 11, 1, 34

    CrossRef

  36. 36
    Elisabetta Tronci, Manolo Carta, 5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation, Basal Ganglia, 2013, 3, 1, 9

    CrossRef

  37. 37
    Elisabetta Tronci, Carlo Lisci, Roberto Stancampiano, Camino Fidalgo, Maria Collu, Paola Devoto, Manolo Carta, 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model, Neurobiology of Disease, 2013, 60, 108

    CrossRef

  38. 38
    Erwan Bézard, Ana Muñoz, Elisabetta Tronci, Elsa Y. Pioli, Qin Li, Gregory Porras, Anders Björklund, Manolo Carta, Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia, Neuroscience Research, 2013, 77, 4, 242

    CrossRef